Skip to main content
. 2015 Dec 3;8(1):29–39. doi: 10.14740/jocmr2405w

Figure 2.

Figure 2

Survival outcomes and leukemia-free survival in PMF patients (n = 77). (a) Kaplan-Meier survival analysis of PMF patients with respect to IDH mutation status. OS was similar between patients with IDH mutations and those with no mutations (mean 125 months; 95% CI: 11 - 238 and 128 months; 95% CI: 98 - 157, respectively; P = 0.351). (b) Leukemia-free survival data for 77 PMF patients stratified by the status of IDH mutations. PMF patients with IDH mutations had shorter LFS compared to patients without IDH mutations (mean 169 months; 95% CI: 159 - 180 and 214 months; 95% CI: 95 - 332, respectively; P = 0.024).